The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 04, 2019

Filed:

Dec. 14, 2016
Applicants:

Max-planck-gesellschaft Zur Förderung, München, DE;

Armin Giese, München, DE;

Felix Schmidt, München, DE;

Inventors:

Armin Giese, München, DE;

Felix Schmidt, München, DE;

Christian Griesinger, Göttingen, DE;

Andrei Leonov, Göttingen, DE;

Sergey Ryazanov, Göttingen, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07F 9/11 (2006.01); A61P 25/28 (2006.01); A61P 25/16 (2006.01);
U.S. Cl.
CPC ...
C07F 9/11 (2013.01); A61P 25/16 (2018.01); A61P 25/28 (2018.01);
Abstract

The present invention is concerned with derivatives of 3,5-diphenyl-diazole compounds, which are effective therapeutic agents for use in treating diseases linked to protein aggregation and/or neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), and Transmissible spongiform encephalopathies (TSEs) such as Creutzfeldt-Jakob disease (CJD). The therapeutic effect is caused by the inhibition of the protein aggregation in the affected tissue, such as the brain. 3,5-Diphenyl-diazole derivatives have been shown to be effective in inhibiting aggregation of proteins but are also characterized by their poor solubility in aqueous solutions. The prodrugs of the invention are modified 3,5-diphenyl-diazole derivatives, which are characterized by their improved solubility in aqueous solutions, and by their increased bioavailability.


Find Patent Forward Citations

Loading…